Xiao Ying Gao
Chief Executive Officer at Bio Products Laboratory Ltd.
Profile
Xiao Ying Gao is currently the Executive Vice Chairman & Chief Executive Officer at Bio Products Laboratory Ltd.
and the Chairman at Guizhou Taibang Biological Products Co., Ltd.
He is also an Independent Director at China Nuokang Bio-Pharmaceutical, Inc. and TaiGen Biotechnology Co., Ltd.
In the past, Mr. Gao held positions such as President & Chief Executive Officer at Beijing Med-Pharm Corp., President, Chief Executive Officer & Director at Abacus Investments Ltd., Chairman, President & Chief Executive Officer at China Biologic Products, Inc., Chief Executive Officer & Director at BMP Sunstone Corp., Chairman & Chief Executive Officer at China Biologic Products Holdings, Inc., Chairman at Beijing Medpharm Co. Ltd., Vice President & Director-Asia & Pacific Business at Motorola, Inc., Director at Motorola China Electronics Co., Ltd., and Director at Motorola, Inc. (Japan).
He also served as a Director at ChinaCast Education Corp., an Independent Director at TaiGen Biopharmaceuticals Holdings Ltd., and a Member-Supervisory Board at Biotest AG.
Additionally, he was a Member-Management Board at Motorola Japan Ltd.
and Tiancheng (Germany) Pharmaceutical Holdings AG.
Mr. Gao obtained an MBA from the Massachusetts Institute of Technology.
He also completed his undergraduate studies at the University of Hannover and Beijing Institute of Technology.
Xiao Ying Gao active positions
Companies | Position | Start |
---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Director/Board Member | 2011-12-19 |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Director/Board Member | - |
Guizhou Taibang Biological Products Co., Ltd.
Guizhou Taibang Biological Products Co., Ltd. Pharmaceuticals: MajorHealth Technology Guizhou Taibang Biological Products Co., Ltd. engages in research, development, production and sale of blood products and biochemical drugs. Its products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin, hepatitis B human immunoglobulin, rabies immune globulin, tetanus human immunoglobulin, human prothrombin complex, and placental polypeptide injection. The company was founded on May 21, 1996 and is head quartered in Guiyang, China. | Chairman | - |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Chief Executive Officer | 2019-03-21 |
Former positions of Xiao Ying Gao
Companies | Position | End |
---|---|---|
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Director/Board Member | 2019-01-01 |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Chief Executive Officer | 2017-12-31 |
CHINACAST EDUCATION CORPORATION | Director/Board Member | 2012-05-10 |
BMP Sunstone Corp.
BMP Sunstone Corp. Medical/Nursing ServicesHealth Services BMP Sunstone Corp. manufactures, markets and distributes over-the-counter products. The company was founded in November 2003 and is headquartered in Montgomery, PA. | Chief Executive Officer | 2009-12-31 |
Beijing Med-Pharm Corp. | President | 2008-02-18 |
Training of Xiao Ying Gao
Massachusetts Institute of Technology | Masters Business Admin |
University of Hannover | Undergraduate Degree |
Beijing Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BIOTEST AG | Health Technology |
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
Private companies | 16 |
---|---|
Motorola, Inc.
Motorola, Inc. Telecommunications EquipmentElectronic Technology Motorola, Inc. provides seamless mobility products and solutions across broadband, embedded systems and wireless networks. Motorola is engaged in providing technologies, products and services for mobile phones. Its portfolio includes wireless handsets, wireless accessories, digital entertainment devices, wireless access systems, voice and data communications systems, and enterprise mobility products. The company operates through three business segments, including Mobile Devices Segment, Home and Networks Mobility Segment and Enterprise Mobility Solutions Segment. The Mobile Devices segment designs, manufactures, sells and services wireless handsets with integrated software and accessory products, and licenses intellectual property. The Home and Networks Mobility segment designs, manufactures, sells, installs and services: (i) digital video, Internet Protocol video and broadcast network interactive set-tops, end-to-end video delivery systems, broadband access infrastructure platforms, and associated data and voice customer premise equipment to cable television and telecom service providers, and (ii) wireless access systems, including cellular infrastructure systems and wireless broadband systems, to wireless service providers. The Enterprise Mobility Solutions segment designs, manufactures, sells, installs and services analog and digital two-way radio, voice and data communications products and systems for private networks, wireless broadband systems and end-to-end enterprise mobility solutions to government and public safety agencies, as well as retail, energy and utilities, transportation, manufacturing, healthcare and other commercial customers. Motorola was founded on September 25, 1928 and is headquartered in Schaumburg, IL | Electronic Technology |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Beijing Med-Pharm Corp. | Distribution Services |
Abacus Investments Ltd.
Abacus Investments Ltd. Medical DistributorsDistribution Services Part of Sanofi, Abacus Investments Ltd. is a Bermudian company that distributes pharmaceutical products to hospitals through its subsidiary. The private company is located in Bermuda. Abacus Investments was acquired by Just Great Coffee, Inc. on February 06, 2004 for $24.59 million. | Distribution Services |
Motorola China Electronics Co., Ltd.
Motorola China Electronics Co., Ltd. Electronic Production EquipmentElectronic Technology Part of Motorola Solutions, Inc., Motorola China Electronics Co., Ltd. is a Chinese company that manufactures and sells electronics products. The private company is based in BEIJING, China. | Electronic Technology |
Motorola, Inc. (Japan)
Motorola, Inc. (Japan) Telecommunications EquipmentElectronic Technology Part of Motorola Solutions, Inc., Motorola, Inc. (Japan) is a Japanese company that imports and markets telecommunication equipment. The private company is based in Tokyo, Japan. | Electronic Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
ChinaCast Education Corp.
ChinaCast Education Corp. Miscellaneous Commercial ServicesCommercial Services ChinaCast Education Corp. provides post-secondary education and e-learning services in China. The company was founded in 1999 and is headquartered in Hong Kong. | Commercial Services |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |
Beijing Medpharm Co. Ltd. | |
BMP Sunstone Corp.
BMP Sunstone Corp. Medical/Nursing ServicesHealth Services BMP Sunstone Corp. manufactures, markets and distributes over-the-counter products. The company was founded in November 2003 and is headquartered in Montgomery, PA. | Health Services |
Motorola Japan Ltd. | |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Health Technology |
Guizhou Taibang Biological Products Co., Ltd.
Guizhou Taibang Biological Products Co., Ltd. Pharmaceuticals: MajorHealth Technology Guizhou Taibang Biological Products Co., Ltd. engages in research, development, production and sale of blood products and biochemical drugs. Its products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin, hepatitis B human immunoglobulin, rabies immune globulin, tetanus human immunoglobulin, human prothrombin complex, and placental polypeptide injection. The company was founded on May 21, 1996 and is head quartered in Guiyang, China. | Health Technology |
China Biologic Products Holdings, Inc.
China Biologic Products Holdings, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. The company was founded in 2002 and is headquartered in Beijing, China. | Health Technology |
Tiancheng (Germany) Pharmaceutical Holdings AG
Tiancheng (Germany) Pharmaceutical Holdings AG Pharmaceuticals: MajorHealth Technology Part of Grifols SA, Tiancheng (Germany) Pharmaceutical Holdings AG is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dusseldorf, Germany. The company was founded in 2017. Tiancheng (Germany) Pharmaceutical Holdings was acquired by Grifols SA from Creat Group Co., Ltd. on April 25, 2022 for $1,273.64 million. | Health Technology |
- Stock Market
- Insiders
- Xiao Ying Gao